Publications

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

 56
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47

Tags:

Previous Article

Opposing roles for AMPK in regulating distinct mitophagy pathways

Next Article

Gene replacement therapy for hereditary spastic paraplegia type 47

Related Posts

Frontostriatal salience network expansion in individuals in depression

Frontostriatal salience network expansion in individual...

 34

Altered expression of Presenilin2 impacts endolysosomal homeostasis and synapse function in Alzheimer’s disease-relevant brain circuits

Altered expression of Presenilin2 impacts endolysosomal...

 50

Inflammasome signaling in astrocytes modulates hippocampal plasticity

Inflammasome signaling in astrocytes modulates hippocam...

 103